Woodline Partners »

Quoin Pharmaceuticals shares owned by Woodline Partners

Quarter-by-quarter ownership of Quoin Pharmaceuticals (QNRX) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Quoin Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Quoin Pharmaceuticals held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quoin Pharmaceuticals by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 80k 14.43

More positions owned by Woodline Partners

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Texas Instruments Incorporated (TXN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Verizon Communications (VZ)
Revolution Medicines (RVMD)

View all positions for Woodline Partners

Top funds holding Quoin Pharmaceuticals

Ikarian Capital
Woodline Partners
Stonepine Capital Management
Standard Life Aberdeen
Boothbay Fund Management
ADAR1 Capital Management
AIGH Capital Management
Resolute Capital Asset Partners
Soleus Capital Management
Simplify Asset Management
Centiva Capital
GAMMA Investing
Rhumbline Advisers
UBS Group
SBI Securities

View all funds holding Quoin Pharmaceuticals